Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...am-negative bacteria, such as Klebsiella pneumoniae and Escherichia coli, can cause severe and often deadly infections that pose a particular threat for people with weak or not yet fully developed immune systems, including newborns, ageing populations, people undergoing surgery and cancer treatment.
The report highlights a worrying gap in activity against the highly resistant NDM-1 (New Delhi metallo-beta-lactamase 1), with only three antibiotics in the pipeline. NDM-1 makes bacteria resistant to a broad range of antibiotics, including those from the carbapenem family, which today are the last line of defence against antibiotic-resistant bacterial infections.
more
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
Towards ending tuberculosis and multidrug-resistant tuberculosis.
No publication date indicated.
The Road to Recovery. This synthesis report is based on three national studies on the evolution of the Ebola epidemic and its impact on Guinea, Liberia and Sierra Leone
Possible developments in transit countries over the next 6 months, 24 March 2016
Frequently Asked Questions on Visceral Leishmaniasis
Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.